Opportunity Information: Apply for RFA 615 13 000003
Apply for RFA 615 13 000003
- The Kenya USAID Nairobi in the health sector is offering a public funding opportunity titled "Accelerating Progress Against TB in Kenya (APA K)" and is now available to receive applicants.
- This funding opportunity was created on Mar 19, 2013 and posted on Mar 1, 2013.
- Applicants must submit their applications by Apr 15, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $40,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $40,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- In response to this RFA, only local Kenyan organizations are eligible to apply. See RFA for eligibility criteria.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Accelerating Progress Against TB in Kenya (APA K) grant opportunity is a USAID-funded health program designed to strengthen and expand tuberculosis (TB) services across Kenya. Issued by USAID Kenya (USAID Nairobi), the opportunity seeks applications for a Cooperative Agreement, meaning the awardee would not simply receive funds and operate independently, but would implement the program with substantial involvement and technical collaboration from USAID. The core purpose is to extend access to quality-assured TB prevention, diagnosis, treatment, and care services in every district, and for all forms of TB, including drug-sensitive and potentially drug-resistant TB. The program emphasizes practical, evidence-based interventions that directly support and complement the Government of Kenya, specifically the Division of Leprosy, TB and Lung Diseases, rather than duplicating existing government work.
In practical terms, APA K is framed around improving nationwide TB service coverage and quality by identifying what works and scaling it in ways that fit Kenya’s health system. The opportunity highlights “evidence-based activities,†which signals an expectation that applicants will propose interventions grounded in proven public health approaches, routine program data, and accepted clinical and programmatic standards. Because the objective is “quality assured TB services,†applicants would typically be expected to focus on strengthening service delivery systems, ensuring adherence to national guidelines, improving case detection and linkage to treatment, supporting treatment completion and patient follow-up, improving laboratory and diagnostic networks, strengthening supervision and quality improvement, and reinforcing monitoring and evaluation so that progress can be measured and used to guide decisions. The emphasis on all districts also implies an intent to reduce geographic gaps in service access, making TB services more consistently available and reliable across the country.
The opportunity is substantial in scale. USAID anticipated making one award, with an estimated total funding amount of USD 40,000,000 and an award ceiling of USD 40,000,000, indicating a single large implementing partner would likely lead the program nationally. The award floor is listed as USD 0, which is often used administratively and does not necessarily mean small awards are expected; combined with the single expected award and the ceiling matching total estimated funding, the intent reads as one main award of up to the full amount. There is no cost sharing or matching requirement, so applicants were not required to contribute their own funds as a condition of eligibility, though they could still propose leveraged resources or partnerships if relevant.
Eligibility is narrowly defined: only local Kenyan organizations are eligible to apply, as stated in the eligibility information. This is important because it signals USAID’s intent to build local leadership and implementation capacity and to place primary responsibility for the program with Kenyan entities. The listing’s applicant category is shown as “Others,†with clarification that the full RFA contains the specific eligibility criteria. In practice, that usually means applicants must meet USAID’s definitions and documentation requirements for local entities, demonstrate organizational capacity to manage a large cooperative agreement, and satisfy compliance standards for U.S. government-funded assistance.
Key administrative details are also clear from the announcement. The funding opportunity number is RFA 615-13-000003. The opportunity was posted on March 1, 2013, created on March 19, 2013, and had an original closing date of April 1, 2013, later extended to April 15, 2013. The archive date is May 1, 2013, meaning the opportunity is no longer open and is retained for records. Questions about accessing the full announcement were directed to Jennifer Kiiru, Acquisition and Assistance Specialist at USAID/EA, reachable at jkiiru@usaid.gov.
Overall, APA K is a major USAID cooperative agreement focused on accelerating TB control outcomes in Kenya by expanding access to high-quality TB services nationwide, using proven interventions aligned with national strategies and implemented by Kenyan organizations in close coordination with the Government of Kenya’s TB program.
Frequently Asked Questions (FAQs) - Accelerating Progress Against TB in Kenya (APA K)
What is the Accelerating Progress Against TB in Kenya (APA K) opportunity?
Accelerating Progress Against TB in Kenya (APA K) is a USAID-funded health program intended to strengthen and expand tuberculosis (TB) services across Kenya. The stated purpose is to extend access to quality-assured TB prevention, diagnosis, treatment, and care services in every district, covering all forms of TB, including drug-sensitive and potentially drug-resistant TB.
Who is issuing and funding this opportunity?
The opportunity is funded by USAID and issued by USAID Kenya (USAID Nairobi).
What type of award is being offered?
This opportunity is for a Cooperative Agreement. That means the awardee would implement the program with substantial involvement and technical collaboration from USAID, rather than operating fully independently after receiving funds.
What is the main goal of APA K?
The core goal is to improve nationwide TB service coverage and quality by scaling practical, evidence-based interventions that fit Kenya's health system. The program aims to ensure quality-assured TB services are accessible across all districts.
What TB services and areas are emphasized?
The opportunity emphasizes TB prevention, diagnosis, treatment, and care services, including support for all forms of TB (drug-sensitive and potentially drug-resistant TB). It highlights quality assurance and broader access across Kenya.
Does the program need to align with the Government of Kenya's TB efforts?
Yes. The opportunity specifically states that activities should directly support and complement the Government of Kenya, particularly the Division of Leprosy, TB and Lung Diseases, and should not duplicate existing government work.
What does "evidence-based activities" mean in this context?
The opportunity signals an expectation that applicants propose interventions grounded in proven public health approaches, routine program data, and accepted clinical and programmatic standards, with an emphasis on what works and scaling it appropriately within Kenya's health system.
What kinds of activities are typically implied by the focus on "quality-assured TB services"?
Based on the description, applicants would typically be expected to focus on strengthening service delivery systems, ensuring adherence to national guidelines, improving case detection and linkage to treatment, supporting treatment completion and patient follow-up, improving laboratory and diagnostic networks, strengthening supervision and quality improvement, and reinforcing monitoring and evaluation so progress can be measured and used for decision-making.
Is the program intended to cover all districts in Kenya?
Yes. The stated emphasis on expanding access to quality-assured TB services "in every district" indicates an intent to reduce geographic gaps and improve consistency and reliability of TB services nationwide.
How many awards did USAID anticipate making?
USAID anticipated making one award, suggesting a single main implementing partner would likely lead the program nationally.
What is the estimated total funding amount?
The estimated total funding amount is USD 40,000,000.
What is the award ceiling?
The award ceiling is USD 40,000,000.
What is the award floor, and what does it mean here?
The award floor is listed as USD 0. The description notes this is often used administratively and does not necessarily indicate small awards are expected; given that one award was anticipated and the ceiling matches the estimated total funding, the opportunity reads as one main award of up to the full amount.
Is cost sharing or matching required?
No. The opportunity states there is no cost sharing or matching requirement. Applicants were not required to contribute their own funds as a condition of eligibility, though they could still propose leveraged resources or partnerships if relevant.
Who is eligible to apply?
Eligibility is limited to local Kenyan organizations, as stated in the eligibility information. The listing notes the applicant category as "Others," and indicates the full Request for Applications (RFA) contains the specific eligibility criteria.
Where can applicants find the full eligibility criteria?
The announcement indicates that the full RFA contains the specific eligibility criteria, beyond the high-level statement that only local Kenyan organizations are eligible.
What is the funding opportunity number?
The funding opportunity number is RFA 615-13-000003.
When was the opportunity posted and created?
The opportunity was posted on March 1, 2013, and created on March 19, 2013.
What was the closing date, and was it extended?
The original closing date was April 1, 2013, and it was later extended to April 15, 2013.
Is this opportunity still open?
No. The archive date is May 1, 2013, which indicates the opportunity is no longer open and is retained for records.
Who was the point of contact for questions about accessing the full announcement?
Questions about accessing the full announcement were directed to Jennifer Kiiru, Acquisition and Assistance Specialist at USAID/EA, reachable at jkiiru@usaid.gov.
What is the expected relationship between the awardee and USAID under this mechanism?
Because the award is a Cooperative Agreement, the awardee is expected to implement the program with substantial involvement and technical collaboration from USAID.
What is the intended implementation approach for APA K?
The opportunity describes an approach focused on identifying what works and scaling it in ways that fit Kenya's health system, while complementing the Government of Kenya's TB program and applying evidence-based interventions.
Browse more opportunities from the same category: Health
Next opportunity: READ Alliance
Previous opportunity: Supporting the implementation and capacity building of HIV/AIDS prevention interventions for youth using evidence based approaches in South Africa under the Presidents Emergency Plan for AIDS Relief (PEPFAR)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA 615 13 000003
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA 615 13 000003) also looked into and applied for these:
| Funding Opportunity |
|---|
| Genomes to Natural Products (U01) Apply for RFA GM 14 002 Funding Number: RFA GM 14 002 Agency: National Institutes of Health Category: Health Funding Amount: $2,250,000 |
| Investigator Initiated Multi Site Clinical Trials (Collaborative R01) Apply for PAR 13 128 Funding Number: PAR 13 128 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alzheimers Disease Research Centers (P50) Apply for RFA AG 13 019 Funding Number: RFA AG 13 019 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Small Business Innovation Research on Rare Musculoskeletal, Rheumatic and Skin Diseases (SBIR) (R43) Apply for RFA AR 14 005 Funding Number: RFA AR 14 005 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Collaborations for Macromolecular Interactions in Cells (R01) Apply for RFA GM 14 004 Funding Number: RFA GM 14 004 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Research Networks for Macromolecular Interactions in Cells (U54) Apply for RFA GM 14 005 Funding Number: RFA GM 14 005 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| NIH Directors Biomedical Research Workforce Innovation Award Broadening Experiences in Scientific Training (BEST) (DP7) Apply for RFA RM 12 022 Funding Number: RFA RM 12 022 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| NGO Health Service Delivery Program Apply for RFA 442 13 000001 Funding Number: RFA 442 13 000001 Agency: Cambodia USAID Phnom Penh Category: Health Funding Amount: $6,600,000 |
| Advancing Eating Disorders Research through Dimensional Studies of Biology and Behavior (R01) Apply for RFA MH 14 030 Funding Number: RFA MH 14 030 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Program for Extramural/Intramural Alcohol Research Collaborations (U01) Apply for PAR 13 133 Funding Number: PAR 13 133 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| HIV Prevention with Key Populations Mali Apply for RFA 688 13 000004 Funding Number: RFA 688 13 000004 Agency: Mali USAID Bamako Category: Health Funding Amount: $2,000,000 |
| Supporting a Caribbean Regional Educational Institution to Deliver Leadership and Management Training to Health Professionals in Eleven Caribbean Partnership Framework Countries under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1348 Funding Number: CDC RFA GH13 1348 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| Preclinical Innovation Program (PIP) (R01) Apply for RFA AI 13 008 Funding Number: RFA AI 13 008 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Mechanisms of Cellular Immunity in the Female Reproductive Tract (R01) Apply for RFA AI 12 054 Funding Number: RFA AI 12 054 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Planning Grants for the NIH National Research Mentoring Network (NRMN) (P20) Apply for RFA RM 13 002 Funding Number: RFA RM 13 002 Agency: National Institutes of Health Category: Health Funding Amount: $130,000 |
| Planning Grants for the NIH Building Infrastructure Leading to Diversity (BUILD) Initiative (P20) Apply for RFA RM 13 001 Funding Number: RFA RM 13 001 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| PsychENCODE Identification and Characterization of Non coding Functional Elements in the Brain, and their Role in the Development of Mental Disorders (R01) Apply for RFA MH 14 020 Funding Number: RFA MH 14 020 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Dimensional Approaches to Research Classification in Psychiatric Disorders (R01) Apply for RFA MH 14 050 Funding Number: RFA MH 14 050 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Gut Microbiome Brain Interactions and Mental Health (R21/R33) Apply for RFA MH 14 080 Funding Number: RFA MH 14 080 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Molecular Atlas of Lung Development Human Tissue Core (HTC)(U01) Apply for RFA HL 14 007 Funding Number: RFA HL 14 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA 615 13 000003", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
